Current understanding and management of allograft vasculopathy

Seminars in Thoracic and Cardiovascular Surgery

Volumn 16, Issue 4, 2004, Pages 386-394

  Lietz, Katherine ^a   Miller, Leslie W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Allograft vasculopathy; Heart transplantation

Indexed keywords

AZATHIOPRINE; CALCIUM ANTAGONIST; CORTICOSTEROID; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ANGIOCARDIOGRAPHY; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MOLECULAR MECHANICS; PATHOGENESIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; VASCULITIS; VIRUS INFECTION;

CORONARY DISEASE; DISEASE PROGRESSION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RISK FACTORS;

EID: 11844302882     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2004.09.004     Document Type: Review

References (101)

1. D.O. Taylor L.B. Edwards M.M. Boucek et al. The Registry of the International Society for Heart and Lung Transplantation Twenty-First Official Adult Heart Transplant Report - 2004 J Heart Lung Transplant 23 2004 796-803
2. M.R. Costanzo D.C. Naftel M.R. Pritzker Heart transplant coronary artery disease detected by coronary angiography A multi-institutional study of preoperative donor and recipient risk factors J Heart Lung Transplant 17 1998 744-753
3. A.M. Keogh H.A. Valantine S.A. Hunt et al. Impact of proximal or mid vessel discrete coronary artery disease on survival after heart transplantation J Heart Lung Transplant 11 1992 892-901
4. H. Tsutsui K.M. Ziada P. Schoenhagen et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: Results from a 5-year serial intravascular ultrasound study Circulation 104 2001 653-657
5. M.E. Billingham Histopathology of graft coronary disease J Heart Lung Transplant 11 Suppl 1992 S38-S44
6. C.K. Wong A.C. Yeung et al. The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: influence of pre-existent donor artherosclerosis J Heart Lung Transplant 20 2001 858-864
7. M.H. Yamani S.A. Haji R.C. Starling et al. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection, and poor long-term outcome J Am Coll Cardiol 39 2002 970-977
8. J.A. Kobashigawa First-year intravascular ultrasound results as a surrogate marker for outcomes after heart transplantation J Heart Lung Transplant 22 2003 711-714
9. S.R. Kapadia S.E. Nissen E.M. Tuzcu Impact of intravascular ultrasound in understanding transplant coronary artery disease Curr Opin Cardiol 14 1999 140-150
10. C.E. Luyt G. Drobinski R. Dorent et al. Prognosis of moderate coronary artery lesions in heart transplant patients J Heart Lung Transplant 22 2003 130-136
11. P.R. Rickenbacher F.J. Pinto N.P. Lewis et al. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation Circulation 92 1995 3445-3452
12. M.R. Mehra H.O. Ventura D.D. Stapleton et al. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy J Heart Lung Transplant 14 1995 632-639
13. F.G. St. Goar F.J. Pinto E.L. Alderman et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening Circulation 85 1992 979-987
14. P.W. Pflugfelder D.R. Boughner L. Rudas et al. Enhanced detection of cardiac allograft arterial disease with intracoronary ultrasonographic imaging Am Heart J 125 1993 1583-1591
15. L.W. Miller Role of intracoronary ultrasound for the diagnosis of cardiac allograft vasculopathy Transplant Proc 27 1995 1989-1992
16. Multicenter Intravascular Ultrasound Transplant Study Group A.C. Yeung S.F. Davis P.J. Hauptman et al. Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound J Heart Lung Transplant 14 1995 S215-S220
17. J.G. Wiedermann J.Z. Weinberger Severe intimal thickening by intravascular ultrasonography predicts early death in cardiac transplant recipients Circulation 90 1994 I93
18. Mehra M.R. Ventrua H.O. Chambers R. et al. Predictive model to assess risk for cardiac allograft vasculopathy: An intravascular ultrasound study. J Am Coll Cardiol 26 1537-1544
19. Tuzcu E.M. Hobbs R.E. Rincon G. et al. Occult and frequent transmission of athrosclerotic cornary disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation 91:1706-1713
20. K. Lietz R. John D.M. Mancini et al. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list: Implications for donor selection criteria J Am Coll Cardiol 43 2004 1553-1561
21. W.F. Enos R.H. Holmes J. Beyer Coronary disease among United States soldiers killed in action in Korea JAMA 152 1953 1090-1093
22. A. Joseph D. Ackerman J.D. Talley et al. Manifestations of coronary atherosclerosis in young trauma victims - An autopsy study J Am Coll Cardiol 22 1993 459-467
23. R.P. Stark A.L. McGinn R.F. Wilson Chest pain in cardiac-transplant recipients. Evidence of sensory reinnervation after cardiac transplantation N Engl J Med 324 1991 1791-1794
24. S.Z. Gao J.S. Schroeder S.A. Hunt et al. Acute myocardial infarction in cardiac transplant recipients Am J Coll Cardiol 64 1989 1093-1097
25. S. Glagov E. Weisenberg C.K. Zarins et al. Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 1987 1371-1375
26. F.A. Dressler L.W. Miller Necropsy versus angiography: How accurate is angiography? J Heart Lung Transplant 11 1992 56-59
27. D.E. Johnson E.L. Alderman J.S. Schroeder et al. Transplant coronary artery disease: Histopathological correlations with angiographic morphology J Am Coll Cardiol 17 1991 449-457
28. K. Ramasubbu P. Schoenhagen M.A. Balghith et al. Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease J Am Coll Cardiol 41 2003 1739-1743
29. J.C. Fang S. Kinlay P. Wexberg et al. Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant associated arteriosclerosis Am J Cardiol 86 2000 890-892
30. A. Konig C.H. Spes T.M. Schiele et al. Coronary Doppler measurements do not predict progression of cardiac allograft vasculopathy: Analysis by serial intracoronary Doppler, dobutamine stress echocardiography, and intracoronary ultrasound J Heart Lung Transplant 21 2002 902-905
31. S.M. Hollenberg L.W. Klein J.E. Parrillo et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death Circulation 104 2001 3091-3096
32. T.L. Wolford T.J. Donohue R.G. Bach et al. Heterogeneity of coronary flow reserve in the examination of multiple individual allograft coronary arteries Circulation 99 1999 626-632
33. F.W. Smart C.M. Ballantyne B. Cocanougher et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant Am J Cardiol 67 1991 243-247
34. G.R. Ciliberto M. Mangiavacchi F. Banfi et al. Coronary artery disease after heart transplantation: Non-invasive evaluation with exercise thallium scintigraphy Eur Heart J 14 1993 226-229
35. K.O. Akosah P.K. Mohanty J.T. Funai et al. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography J Heart Lung Transplant 13 1994 1024-1038
36. C.H. Spes V. Klauss H. Mudra et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: A comparison with coronary angiography and intravascular ultrasound Circulation 100 1999 509-515
37. M. Dandel M. Hummel J. Muller et al. Reliability of tissue Doppler wall motion monitoring after heart transplantation for replacement of invasive routine screenings by optimally timed cardiac biopsies and catheterizations Circulation 104 2001 I184-I191
38. O.M. Muehling N.M. Wilke P. Panse et al. Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging J Am Coll Cardiol 42 2003 1054-1060
39. M.R. Mehra A. Prasad P.A. Uber et al. The impact of explosive brain death on the genesis of cardiac allograft vasculopathy: An intravascular ultrasound study J Heart Lung Transplant 19 2000 522-528
40. D.C. McGiffin T. Savunen J.K. Kirklin et al. Cardiac transplant coronary artery disease: A multivariable analysis of pretransplantation risk factors for disease development and morbid events J Cardiovasc Surg 109 1995 1081-1089
41. P. Herijgers V. Leunens T.B. Tjandra-Maga et al. Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines Transplantation 62 1996 330-335
42. A.G. Rose D. Novitzky S.M. Factor Catecholamine-associated smooth muscle contraction bands in the media of coronary arteries of brain-dead baboons Am J Cardiovasc Pathol 21 1988 63-67
43. M.J. Wilhelm J. Pratschke F. Beato et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation Circulation 102 2000 2426-2433
44. D.A. Shoskes N.A. Parfrey P.F. Halloran Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse Transplantation 49 1990 201-207
45. S.C. Stoica M. Goddard S.R. Large The endothelium in clinical cardiac transplantation Ann Thorac Surg 73 2002 1002-1008
46. S.F. Davis A.C. Yeung I.T. Meredith et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant Circulation 93 1996 475-462
47. P.S. Russell C.M. Chase H.J. Winn et al. Coronary atherosclerosis in transplanted mouse hearts: I. Time course and immunogenetic and immunopathological considerations J Am Pathol 144 1994 260-269
48. M.R. Constanzo-Nordin Cardiac allograft vasculopathy: Relationship with acute cellular rejection and histocompatibility J Heart Lung Transplant 11 1992 90-104
49. E.R. Vasilescu E.K. Ho L. de la Torre et al. Anti-HLA antibodies in heart transplantation Transpl Immunol 12 2004 177-183
50. A.D. Burnette K. Mohler L. McHugh et al. Ten year overview of defining a chronic rejection-free state by donor-antigen-specific hyporeactivity Hum Immunol 64 2003 S40 abstr
51. B. Radovancevic S. Poindexter S. Birovljev et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients Eur J Cardiothorac Surg 4 1990 309-313
52. A.Z. Gao J.S. Shroeder S.A. Hunt et al. Influence of graft rejection on incidence of accelerated graft coronary artery disease: A new approach to analysis J Heart Lung Transplant 12 1993 1029-1035
53. P.G.I. Stovin L.D. Sharples P.M. Schofield et al. Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease J Heart Lung Transplant 12 1993 110-116
54. M.H. Yamani M. Yousufuddin R.C. Starling et al. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant 23 2004 272-276
55. J.A. Kobashigawa L. Miller A. Yeung et al. Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound: Sandoz/CVIS Investigators J Heart Lung Transplant 14 1995 S221-S226
56. M.H. Yamani M. Tuzcu R.C. Starling et al. Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound J Heart Lung Transplant 21 2002 850-859
57. C.C. Marboe M. Billingham H.J. Eisen et al. Refining pathological classification of acute rejection in cardiac allograft recipients: A multicenter study using peripheral blood gene expression profiling 2004 Presented at the Twenty-First Annual Meeting of The International Society for Heart and Lung Transplantation, San Francisco, CA, April 20-23
58. M.R. Mehra J. Kobashigawa S. Hunt et al. Molecular testing and prediction of clinical outcome in heart transplantation: A prospective multicenter trial J Heart Lung Transplant 23 2004 S106
59. A. Escobar H.O. Ventura D.D. Stapleton et al. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors Am J Cardiol 74 1994 1042-1046
60. 12, folate, homocysteine, and creatinine in predicting outcomes in heart transplant recipients Am J Cardiol 89 2002 834-837
61. R.L. Benza G.J. Zoghbi J. Tallaj et al. Palliation of allograft vasculopathy with transluminal angioplasty: A decade of experience J Am Coll Cardiol 43 2004 1973-1981
62. Y. Takano J.W. Currier L.A. Yeatman et al. Cutting balloon angioplasty for cardiac transplant vasculopathy J Heart Lung Transplant 21 2002 910-913
63. A.A.I. Halle G. DiSciascio E.K. Massin et al. Coronary angioplasty, atherectomy, and bypass surgery in cardiac transplant recipients J Am Coll Cardiol 26 1995 120-128
64. M. Redonnet C. Tron R. Koning et al. Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation Transplant Proc 32 2000 463-465
65. R. Lamich M. Ballester V. Marti Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation J Am Coll Cardiol 32 1998 413-419
66. J. Kobishigawa L.W. Stevenson E.D. Brownfield et al. Initial success of steroid weaning late after heart transplantation J Heart Lung Transplant 1 1992 428-430
67. L.W. Miller T. Wolford L.R. McBride et al. Successful withdrawal of corticosteroids in heart transplantation J Heart Lung Transpl 11 1992 431-434
68. Mycophenolate Mofetil Investigators J. Kobashigawa L. Miller D. Renlund et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients Transplantation 66 1998 507-515
69. H. Shimizu M. Takahashi S. Takeda et al. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation Transplantation 77 2004 1661-1667
70. A. Raisanen-Sokolowski P. Vuoristo M. Myllarniemi et al. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts Transpl Immunol 3 1995 342
71. M.L. Rose J. Smith G. Dureau et al. Mycophenolate mofetil decreases antibody production after cardiac transplantation J Heart Lung Transplant. 22 2002 282-285
72. K. Lietz R. John M. Schuster et al. Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients Transplant Proc 34 2002 1828
73. U. Heemann H. Azuma P. Hamar et al. Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts Transpl Immunol 4 1996 64
74. J.D. Hosenpud L.E. Bennett Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: An analysis of the Joint UNOS/ISHLT Thoracic Registry Transplantation J Heart Lung Transplant 72 2001 1662-1665
75. S.Z. Gao J.S. Schroeder E.L. Alderman et al. Prevalence of accelerated coronary artery disease in heart transplant survivors: Comparison of cyclosporine and azathioprine regimens Circulation 80 1989 100-105
76. K. Sudhir J.S. MacGregor T. DeMarco et al. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries Circulation 90 1994 3018-3023
77. A. Gamba F. Mamprin R. Fiochi et al. The risk of coronary artery disease after heart transplanation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels Clin Cardiol 20 1997 767-772
78. D.O. Taylor M.L. Barr B. Radovancevic et al. A randomized, multicenter comparison of tracrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus J Heart Lung Transplant 18 1999 336-345
79. European Tacrolimus Multicenter Heart Study Group B. Reichart B. Meiser M. Bigano et al. European multicenter tacrolimus (FK506) heart pilot study: One-year results J Heart Lung Transplant 17 1998 775-781
80. M. Rinaldi C. Pellegrini L. Martinelli et al. FK506 effectiveness in reducing acute rejection after heart transplantation: A prospective randomized study J Heart Lung Transplant 10 1997 1001-1009
81. T. Shibata N. Ogawa I. Koyoma et al. Does FK506 accelerate the development of coronary artery disease in the transplant heart as well as in the native heart? Transplant Proc 25 1993 1145-1148
82. A. Keogh M. Richardson P. Ruygrok et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years. A randomized clinical trial Circulation 2004 (in press)
83. D. Mancini S. Pinney D. Burkhoff et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy Circulation 108 2003 48-53
84. Z.A. Massy Hyperlipidemia and cardiovascular disease after organ transplantation Transplantation 72 2001 S13-S15
85. E.M. Tuzcu P. Schoenhagen R.C. Starling et al. Impact of everolimus on allograft vasculopathy: The SDZ RAD/heart intravascular ultrasound study J Heart Lung Transplant 21 2002 68
86. H.J. Eisen E.M. Tuzscu R. Dorent et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients N Engl J Med 349 2003 847-856
87. K. Hoang Y.D. Chen G. Reaven et al. Diabetes and dyslipidemia. A new model for transplant coronary artery disease Circulation 97 1998 2160-2168
88. D. Eich J.A. Thomson D. Ko Hypercholesterolemia in long-term survivors of heart transplantation: An early marker of accelerated coronary artery disease J Heart Lung Transplant 10 1991 45-49
89. J.A. Kobashigawa S. Katznelson H. Laks et al. Effect of pravastatin on outcomes after cardiac transplantation N Engl J Med 333 1995 621-627
90. J.A. Kobashigawa Statins in solid organ transplantation: Is there an immunosuppressive effect? Am J Transplant 4 2004 1013-1018
91. M.R. Mehra P.A. Uber K. Vivekananthan et al. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival J Am Coll Cardiol 40 2002 1609-1614
92. K. Wenke B. Meiser J. Thiery et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience Circulation 107 2003 93-97
93. M.R. Mehra H.O. Ventura F.W. Smart et al. An intravascular ultrasound study of the influence of angiotensinconverting enzyme inhibitors and calcium entry channel blockers on the development of cardiac allograft vasculopathy J Am Cardiol 75 1995 853-854
94. J.S. Schroeder S.-Z. Gao E.L. Alderman et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients N Engl J Med 328 1993 164-170
95. M.R. Mehra H.O. Ventura F.W. Smart et al. An intravascular ultrasound study of the influence of angiotensinconverting enzyme inhibitors and calcium entry channel blockers on the development of cardiac allograft vasculopathy J Am Cardiol 75 1995 853-854
96. B. Depczynski B. Daly L.V. Campbell et al. Predicting the occurrence of diabetes mellitus in recipients of heart transplants Diabet Med 17 2000 15-19
97. H. Valantine P. Rickenbacker M. Kemna et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease Circulation 103 2001 2144-2152
98. C.C. Lang A. Beniaminovitz N. Edwards et al. Morbidity and mortality in diabetic patients following cardiac transplantation J Heart Lung Transplant 22 2003 244-249
99. M.T. Grattan C.E. Moreno-Cabral V.A. Stames et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561-3566
100. K. Lenstrom P. Koskinen L. Krogerus et al. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection Circulation 92 1993 2594-2604
101. M. Loebe S. Schuler O. Zais et al. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart J Heart Transplant 9 1990 707